Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

100%

4 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(75.0%)
Phase 3
1(25.0%)
4Total
Phase 4(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03749902Phase 4Completed

A Randomized Trial of Oral Misoprostol Alone Versus Oral Misoprostol Followed by Oxytocin for Labour Induction

Role: collaborator

NCT01912677Phase 4Completed

Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy

Role: collaborator

NCT01801410Phase 3Completed

Induction With Foley OR Misoprostol (INFORM) Study

Role: collaborator

NCT01030627Phase 4Completed

Treatment Approaches to Preeclampsia

Role: collaborator

All 4 trials loaded